08.30-08.40: Introduction
08.40-09.45: Basic science in severe asthma: what is new (Peter Korošec, Ramesh Kurukulaaratchy)
08.40-09.05: Peter Korošec: Basic science in severe asthma: Pathophysiology and mechanisms
09.05-09.30: Matija Rijavec: Basic science in severe asthma: Biomarkers and genetics
09.30-09.45: Discussion
09.45-11.15: Problematic case reports with discussion/workshop – 1st part (Ramesh Kurukulaaratchy, Sabina Škrgat)
9.45-10.05: Saša Rink: Development of Allergic Bronchopulmonary Mycosis During Benralizumab Treatment
10.05-10.25: Žiga Piletič: Steroid burden in asthma – a case report
10.25-10.45: Anamarija Štajduhar, Marina Lampalo: Complicated asthma in an obese patient
10.45-11.05: Ivan Čekerevac: Hypereosinophilia and severe asthma
11.05-11.15: Additional discussion time (if needed)
11.15-11.35: Coffee break
11.35-13.20: Perspectives and clinical outcomes in severe asthma (Stefano Del Giacco, Mihaela Zidarn)
11.35-12.05: Ramesh Kurukulaaratchy: Comorbidities and Multimorbidity – Important New Perspectives in Severe Asthma
12.05-12.30: Stefano Del Giacco: Remission in asthma
12.30-12.55: Sabina Škrgat: Outcomes and challenges in severe asthma with fungal senzitisation
12.55-13.20: Discussion
13.20- 13.40: Satelitte symposium AstraZeneca: Stefano Del Giacco, Unlocking Airways: Benralizumab’s Pioneering Role in Severe Asthma Management
13.40-14.30: Lunch
14.30-16.30: Reports from clinics and real life studies (Peter Kopač, Branislava Milenković)
14.30-14.45: Sanja Hromiš: Weight-adjusted biologic therapy – are there some benefits?
14.45-15.00: Mirna Vergles: A new rhythm in severe asthma management: extending the intervals for biologics?
15.00-15.15: Irena Šarc: Biologic Therapy in eosinophil COPD: Insights from Our Clinical Experience
15.15-15.30: Peter Kopač: The Significance of Eosinophil Location in Severe Asthma: Insights from Induced Sputum
15.30-15.45: Luka Kunej, Sabina Škrgat: Clinical and molecular response to dupilumab treatment in patients with eosinophilic asthma
15.45-16.15: Discussion
16.15-16.35: Satelitte symposium AstraZeneca: Mark Kačar, Saša Rink, Natalija Edelbaher: TSLP – This Special Little Protein, what it does and how it can help us
16.35-17.00: Coffee break
17.00-18.15: Problematic case reports with discussion – 2nd part (Ivan Čekerevac, Žarko Vrbica)
17.00-17.20: Marija Gomerčić Palčić: Patient with Severe Eosinophilic Asthma and CRSwNP Who Developed EGPA While Being Treated with Benralizumab
17.20-17.40: Jasmina Bošnjić: Asthma and pulmonary embolism
17.40-18.00: Špela Kosi: The Importance of Diagnosing and Treating OSA in Patients with Severe Asthma
18.00-18.15: Additional discussion time (if needed)
18:15-19:05: Satelitte symposium Sanofi. From Clinical Trials to Real Life: How Dupilumab is Changing Practice (Jure Urbančič)
Jure Urbančič: Introduction: T2I is the common denominator
Mirna Vergles: Severe asthma: Can clinical remission be achieved?
Mihkel Plaas: Is precision medicine possible for CRSwNP?
Panel discussion
20.00: Dinner
